Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hanwha Aerospace (012450) – Paid-in Capital Increase Decision of Subsidiary / 2025-02-18 Disclosures
  • [Disclosure] Hana Micron (067310) – Additional Listing (Conversion of Domestic Private CB) / 2024-03-26 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Hyundai Motor Securities | TSMC Packaging Alliance · 1Q24 Earnings Surprise · BUY Rating Maintained / 2024-04-26 RESEARCH
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-03-09 Disclosures
  • [Disclosure] SK Square (402340) – Occurrence of Serious Industrial Accident / 2026-06-26 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – IBK Securities | AI Servers · Server DRAM · Supply Tightness / 2026-04-15 RESEARCH
  • [Disclosure] Celltrion (068270) – Future Business and Management Plan / 2024-09-09 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Results of Annual General Meeting of Shareholders / 2024-03-21 Disclosures

Category: Disclosures

[Disclosure] SK Square (402340) – Decision on Early Acquisition of Treasury Exchangeable Bonds Prior to Maturity / 2026-04-28

Posted on April 28, 2026July 31, 2026 By K-STOCK Editor
[Disclosure] SK Square (402340) – Decision on Early Acquisition of Treasury Exchangeable Bonds Prior to Maturity  / 2026-04-28

Fact Source: Financial Supervisory Service DART 💡 Summary SK Square’s subsidiary, SK Hynix, has decided to exercise its call option (Clean Up Call) to fully acquire and retire its remaining overseas exchangeable bonds worth approximately KRW 132.68B prior to maturity, as the outstanding balance dropped below 10% of the initial issuance. 📊 Key Disclosure Contents…

Read More “[Disclosure] SK Square (402340) – Decision on Early Acquisition of Treasury Exchangeable Bonds Prior to Maturity / 2026-04-28” »

Disclosures, Semiconductors

[Disclosure] KEPCO (015760 / KEP) – Results of Extraordinary General Meeting of Shareholders / 2026-04-27

Posted on April 27, 2026August 12, 2026 By K-STOCK Editor
[Disclosure] KEPCO (015760 / KEP) – Results of Extraordinary General Meeting of Shareholders / 2026-04-27

Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO announced that the proposal to appoint one executive director (Kim Jae-gun) was approved at its Extraordinary General Meeting of Shareholders. 📊 Key Disclosure Content & Financial Highlights • Disclosure Title: Results of Extraordinary General Meeting of Shareholders • Record Date for Voting…

Read More “[Disclosure] KEPCO (015760 / KEP) – Results of Extraordinary General Meeting of Shareholders / 2026-04-27” »

Disclosures, Energy

[Disclosure] Hanwha Ocean (042660) – Provisional Performance (Consolidated Financial Results) / 2026-04-27

Posted on April 27, 2026August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Provisional Performance (Consolidated Financial Results) / 2026-04-27

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean has disclosed its provisional Q1 2026 consolidated financial results, reporting an operating profit of KRW 441.1B (+70.6% YoY, +78.2% QoQ) and a net profit of KRW 500.0B (+131.8% YoY). 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verifying…

Read More “[Disclosure] Hanwha Ocean (042660) – Provisional Performance (Consolidated Financial Results) / 2026-04-27” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Systems (272210) – Provisional Financial Results (Fair Disclosure) / 2026-04-27

Posted on April 27, 2026August 10, 2026 By K-STOCK Editor
[Disclosure] Hanwha Systems (272210) – Provisional Financial Results (Fair Disclosure) / 2026-04-27

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems announced its provisional consolidated financial results for Q1 2026. Q1 revenue reached KRW 807.10B (+16.95% YoY) and operating profit reached KRW 34.28B (+1.94% YoY), while net profit turned to a loss YoY at KRW -95.75B. 📊 Key Disclosure Contents & Financial Figures 📝 Editor’s…

Read More “[Disclosure] Hanwha Systems (272210) – Provisional Financial Results (Fair Disclosure) / 2026-04-27” »

Disclosures, Defense

[Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Holding / 2026-04-27

Posted on April 27, 2026August 10, 2026 By K-STOCK Editor
[Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Holding / 2026-04-27

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems announced that it will hold Investor Relations (IR) sessions from April 28 to April 30, 2026, for major domestic institutional investors to present its Q1 2026 financial results and hold a Q&A session. 📊 Key Disclosure Contents & Financial Figures 📝 Editor’s Comment (Key…

Read More “[Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Holding / 2026-04-27” »

Disclosures, Defense

[Disclosure] Celltrion (068270) – Application for Amendment of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Korea (Correction) / 2026-04-24

Posted on April 24, 2026August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Application for Amendment of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Korea (Correction) / 2026-04-24

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion has disclosed the previously withheld information regarding the number of trial subjects (220 patients) for its CT-P51 Phase 3 IND amendment in Korea following regulatory approval. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Disclosed Metrics and…

Read More “[Disclosure] Celltrion (068270) – Application for Amendment of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Korea (Correction) / 2026-04-24” »

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Approval of IND Amendment for CT-P51 (Keytruda Biosimilar) Korea Phase 3 Clinical Trial / 2026-04-24

Posted on April 24, 2026August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Approval of IND Amendment for CT-P51 (Keytruda Biosimilar) Korea Phase 3 Clinical Trial / 2026-04-24

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion has confirmed approval from the Ministry of Food and Drug Safety (MFDS) in South Korea for an IND amendment application regarding the Phase 3 clinical trial of CT-P51 (a Keytruda biosimilar candidate). 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Read More “[Disclosure] Celltrion (068270) – Approval of IND Amendment for CT-P51 (Keytruda Biosimilar) Korea Phase 3 Clinical Trial / 2026-04-24” »

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-04-24

Posted on April 24, 2026August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-04-24

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean has filed a correction disclosure regarding its contract for 1 unit of FCS (Field Control Facility) with an Oceanian shipowner, updating the contract amount from KRW 899.4B to KRW 902.8B. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Read More “[Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-04-24” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Aerospace(012450) – Clarification of Rumors or Reports (Unconfirmed) / 2026-04-24

Posted on April 24, 2026August 9, 2026 By K-STOCK Editor
[Disclosure] Hanwha Aerospace(012450) – Clarification of Rumors or Reports (Unconfirmed) / 2026-04-24

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Aerospace signed a binding MOU with Spanish defense firms regarding K9 self-propelled howitzers and is currently discussing specific contract terms, though the execution of a final contract remains unconfirmed. 📊 [Key Disclosure Details & Financial Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring ongoing…

Read More “[Disclosure] Hanwha Aerospace(012450) – Clarification of Rumors or Reports (Unconfirmed) / 2026-04-24” »

Disclosures, Defense

[Disclosure] Hyundai Motor (005380) – Decision on Acquisition of Shares and Investment Securities in Other Corporation (Voluntary Disclosure) / 2026-04-24

Posted on April 24, 2026August 11, 2026 By K-STOCK Editor
[Disclosure] Hyundai Motor (005380) – Decision on Acquisition of Shares and Investment Securities in Other Corporation (Voluntary Disclosure) / 2026-04-24

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor has decided to acquire shares of a newly established entity (HMG Future Complex Corp., tentative) for approximately KRW 2.89T in cash to secure a new R&D and business hub. 📊 [Key Disclosure Content & Financial Highlights] 1. Acquisition Details 2. Purpose & Acquisition Method…

Read More “[Disclosure] Hyundai Motor (005380) – Decision on Acquisition of Shares and Investment Securities in Other Corporation (Voluntary Disclosure) / 2026-04-24” »

Disclosures, Automotive

Posts pagination

Previous 1 … 27 28 29 … 252 Next
  • [Disclosure] SK Square (402340) – Decision on Record Date for Cash/In-Kind Dividend / 2025-07-23 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Reference Price for Ex-Interim (Quarterly) Dividend / 2025-11-26 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Other Information / 2024-06-19 Disclosures
  • [Disclosure] Jeju Semiconductor(080220) – Change in Sales or Profit/Loss Structure by 30% (15% for Large Corporations) or More / 2026-02-23 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Decision on Loan to Related Party (Correction) / 2024-10-14 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Decision on Loan to Related Party / 2024-09-11 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Listing of Shares on Foreign Securities Market / 2026-07-13 Disclosures
  • [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-13 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme